Last reviewed 2026-04-20 · How we verify

Low Volume iso-osmolar non-ionic radio contrast medium

VA Greater Los Angeles Healthcare System · FDA-approved active Small molecule Quality 2/100

Low Volume iso-osmolar non-ionic radio contrast medium is a Small molecule drug developed by VA Greater Los Angeles Healthcare System. It is currently FDA-approved. Also known as: Visipaque 320.

At a glance

Generic name	Low Volume iso-osmolar non-ionic radio contrast medium
Also known as	Visipaque 320
Sponsor	VA Greater Los Angeles Healthcare System
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Low Volume iso-osmolar non-ionic radio contrast medium CI brief — competitive landscape report
Low Volume iso-osmolar non-ionic radio contrast medium updates RSS · CI watch RSS
VA Greater Los Angeles Healthcare System portfolio CI

Frequently asked questions about Low Volume iso-osmolar non-ionic radio contrast medium

What is Low Volume iso-osmolar non-ionic radio contrast medium?

Low Volume iso-osmolar non-ionic radio contrast medium is a Small molecule drug developed by VA Greater Los Angeles Healthcare System.

Who makes Low Volume iso-osmolar non-ionic radio contrast medium?

Low Volume iso-osmolar non-ionic radio contrast medium is developed and marketed by VA Greater Los Angeles Healthcare System (see full VA Greater Los Angeles Healthcare System pipeline at /company/va-greater-los-angeles-healthcare-system).

Is Low Volume iso-osmolar non-ionic radio contrast medium also known as anything else?

Low Volume iso-osmolar non-ionic radio contrast medium is also known as Visipaque 320.

What development phase is Low Volume iso-osmolar non-ionic radio contrast medium in?

Low Volume iso-osmolar non-ionic radio contrast medium is FDA-approved (marketed).

Manufacturer: VA Greater Los Angeles Healthcare System — full pipeline
Also known as: Visipaque 320
Compare: Low Volume iso-osmolar non-ionic radio contrast medium vs similar drugs
Pricing: Low Volume iso-osmolar non-ionic radio contrast medium cost, discount & access